Log In
BCIQ
Print this Print this
 

vorapaxar (Zontivity) (MK-5348) (formerly SCH 530348)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionProtease-activated receptor 1 (PAR1) antagonist that inhibits thrombin-induced platelet activation
Molecular Target Protease-activated receptor 1 (PAR1) ; Thrombin receptor
Mechanism of ActionThrombin receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$25.0M

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/07/2016

$25.0M

$25.0M

0

Get a free BioCentury trial today